For anyone who has not been following these
developments closely, from 1 April it becomes mandatory in Mental Health to
start using so-called ‘Clusters’ to classify cases, and include them within the process of contracting for care. There is general recognition that we are still
a long way from being able to base budgets exclusively on Clusters, let alone
set a national tariff for them: there is simply too much variation among cases
within Clusters, or more precisely too much unexplained
variation between them, to allow them to be used reliably in this way.
On the other hand, it is a
breakthrough that large numbers of Mental Health Trusts are at
least applying the Clusters to their records. One of the conference
speakers mentioned that his Trust was achieving nearly 98% coverage, though he
was candid enough to admit that he had his own doubts about the figure: in
relation to just what should he be measuring the percentage? There is a grey
area of definition between what should be included in Clustering and what
should be excluded, so getting a precise percentage is difficult.
Even so, it’s clear that a high proportion of cases are now
being Clustered, and that’s a major advance. It means that we can
at last begin to see just how well Clustering is working, to assess the level
of variability and, ideally, to work out what is acceptable variation and what
is not. In particular, we need to find out where variation is simply down to the way Clustering is being applied.
Because Clustering isn’t like HRG or American DRG grouping,
and not just because there are only 20 or so Clusters as opposed to nearly 1200 HRGs. The biggest difference is that HRGs can be derived by an
automated system based on data already recorded against patient records — diagnoses, procedures, lengths of stay, etc. — whereas Clusters are based on a
professional’s assessment of the case.
This makes the extent of variation in treatment within a
single Cluster unsurprisingly high. For example, another speaker reported on
the results of a survey of over fifty Mental Health Trusts. Within Cluster 11
alone, the cost per day of treatment varies from Trust to Trust from a few
pounds up to nearly £550:
Cost per day variation across Trusts — within a single Cluster |
There are at least three possible explanations of this
variation:
- Wrong Clusters: the clinician’s assessment is incorrect. In this context, a speaker at the conference mentioned the ‘Richmond-Lambeth’ syndrome: mental health problems tend to be far more pronounced in the under-privileged London borough of Lambeth than in relatively well-heeled Richmond; will that lead psychiatrists in Richmond to include in the more severe Clusters service users who may be more seriously ill than many others of their case mix, but far less than those included in similar Clusters in Lambeth? Even without such general trends, it is of course possible that individual cases can slip into an inappropriate Cluster.
- Poorly-defined Clusters: some of the Clusters may be too broadly defined and therefore cover cases that are not entirely homogeneous, but include service users whose condition differs too much in severity for their treatment to be comparable.
- There are genuine variations in clinical practice within a Cluster of reasonably homogeneous service users.
On the other hand, in the short term it is certainly the
first two that are going to attract most of our attention. Until that kind of
problem can be ruled out as a possible cause of the differences we see between
cases and between providers, we can’t really use the data for analysing the
third type of variation. And, above all, we certainly can’t use the Clusters as
a reliable guide to cost.
So the first stage of the exercise is going to be looking
into what exactly lies behind each of the Clusters and what is causing the
observed differences. As we do that, we shall start to build a picture of what
we would normally expect to see in
the way of a mix of treatment types within a Cluster: between so many and so
many outpatient appointments or community visits, between so many and so many
admissions or days of inpatient care.
In other words, we shall start to build definitions of
the packages of care that are associated with Clusters. When we have those, we
shall be able to identify treatment profiles that differ significantly from the
norm.
Now there’s nothing exclusive to Mental Health in
this approach to defining bundles or packages of care. We can build them for
Mental Health care clusters, but why not for somatic diseases too? Why not for
congestive heart failure, diabetes or even different types of cancer? Indeed,
for any long term condition?
Because this kind of work is breaking down another of the
deeply-established barriers in healthcare, between somatic and psychiatric
care. Anything that requires treatment over a long period, in different care
settings, perhaps by different providers, lends itself to this kind of package
of care approach. It’s by no means limited to Mental Health only.
Nor is it limited to British healthcare only: much of the
thinking behind the launching of Accountable Care Organisations in the United
States is also concerned with having a single body responsible for care in a
variety of settings by a range of different institutions. There is nothing surprising
about this convergence: it is a piece of increasingly accepted wisdom that
anything up to 40% of what we previously thought of as acute care is evolving into chronic condition management (with Cancer as perhaps the most
striking example). Inevitably, that is driving us all, everywhere, to undertake this kind of work.
So again it was interesting to discover that many of the
people attending the Mental Health conference also had responsibility for helping to manage Long
Term Conditions. The need to think in terms of packages of care spans
traditionally distinct fields.
Interesting times ahead. And, not for the first time, I was
struck by how Mental Health is showing the way.
There are some interesting challenges ahead. Not least is what lay behind what several speakers pointed out: they didn’t
like talking about Payment by Results. They felt that the initials ‘PbR’ should
be viewed as standing for ‘Payment by Recovery.’
A refreshing view, and one that fits well with the package of care approach. After all, how do you know a package is complete except when the patient has recovered?
But can you imagine the impact on healthcare if remuneration started to be based on outcome?